|
|
 |
OnBioVC
2010-03-11 |
|
Site traffic and subscribers have both been on the rise here at OnBioVC.com; we are both humbled and appreciative for this growth, and that is why now, it is important to listen to what the OnBioVC...
|
|
|
|
|
OnBioVC
2010-03-11 |
|
The ‘Looking for Some (More) of This?’ series is focused upon the tracking of newly formed venture funds who are financing biomedical innovation.
Whilst many continue to pound the drum echoing the ...
|
|
|
|
|
OnBioVC
2010-03-11 |
|
OnBioVC would like to thank our sponsors, without whom complete coverage of the life science venture capital, M&A and IPO sector would not be possible:
Freestone Group | Integrated Solutions f...
|
|
|
|
|
OnBioVC
2010-03-11 |
|
Nautilus Neurosciences (Bridgewater, NJ) near commercial-stage specialty neurology pharma focused on migraine and acute pain, closed a $14.5M Series A financing. Participants include Tailwind Capit...
|
|
|
|
|
OnBioVC
2010-03-10 |
|
NABsys (Providence, RI) a development-stage company focused on polymerase-free solid-state electronic detection DNA sequencing free of amplification or labeling focused point-of-care clinical use, ...
|
|
|
|
|
OnBioVC
2010-03-08 |
|
Pulmonx (Redwood City, CA) a commercial-stage medical device company focused on minimally invasive devices for the diagnosis and treatment of COPD and other pulmonary disorders, closed a $32M Serie...
|
|
|
|
|
OnBioVC
2010-03-08 |
|
Seahorse Bioscience (Billerica, MA) commercial-stage providers of instruments for cellular bioenergetic measurements for better understanding of the role of mitochondrial function in obesity, diabe...
|
|
|
|
|
OnBioVC
2010-03-04 |
|
Pearl Therapeutics (Redwood City, CA) a clinical-stage pharma company focused on metered dose inhaler products for the treatment of COPD and asthma, closed a $15M Series C financing. Participants i...
|
|
|
|
|
OnBioVC
2010-03-03 |
|
Merus (Netherlands) a preclinical-stage biopharmaceutical focused on antibody product candidates against targets in oncology, inflammation and infectious disease, closed a $30.7M Series B financing...
|
|
|
|
|
OnBioVC
2010-03-03 |
|
Kolltan Pharmaceuticals (New Haven, CT) a development-stage biopharmaceutical company focused on monoclonal antibody oncology therapeutics, closed a $8.5M Series B financing. Participants include C...
|
|
|
|
|
|
|
|
OnBioVC
2010-03-03 |
|
ImpactRx (Mt. Laurel, NJ) a commercial-stage provider of online content measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation’s highest value physicians, closed...
|
|
|
|
|
OnBioVC
2010-03-02 |
|
MicroCHIPS (Bedford, MA) a development-stage medical device company focused on implantable drug delivery and biosensing for diabetes and osteoporosis, closed a $16.5M Series C financing. Participan...
|
|
|
|
|
OnBioVC
2010-03-02 |
|
TheraSim (Durham, NC) a commercial-stage medical technology company focused on a suite of clinical performance management tools, closed a $1.2M Series A financing. Participants include Andromeda Ca...
|
|
|
|
|
OnBioVC
2010-03-01 |
|
Advanced Cardiac Therapeutics (Laguna Beach, CA) a development-stage electrophysiology and radiometry medical device company focused on energy delivery via catheters for cardiac ablation, closed a ...
|
|
|
|
|
OnBioVC
2010-03-01 |
|
Tandem Diabetes Care (San Diego, CA) a development-stage medical device company focused on insulin pump technology, closed a $30.8M Series C financing, bringing the total round to $52.3M. Participa...
|
|
|
|
|
OnBioVC
2010-03-01 |
|
F-star Biotech (Austria) a development-stage based biopharma company focused upon an antibody design platform, with product and indication(s) to be identified, closed a $10.8M Series A financing, b...
|
|
|
|
|
OnBioVC
2010-02-24 |
|
Neomend (Irvine, CA) a commercial-stage developer of sealant and adhesion-prevemtion products focused on the application to visceral pleura for open thoracotomy, closed a $30M Series D financing. P...
|
|
|
|
|
OnBioVC
2010-02-24 |
|
Elevation Pharmaceuticals (San Diego, CA) a preclinical-stage biopharmaceutical company focused on developing improved inhaled drug therapies for COPD , closed a $30M Series A financing. Participan...
|
|
|
|
|
OnBioVC
2010-02-23 |
|
Alnara Therapeutics (Cambridge, MA) a clinical-stage biopharmaceutical company focused on liprotamase, a pancreatic enzyme replacement therapy, for the treatment of pancreatic insufficiency associa...
|
|
|
|
|
OnBioVC
2010-02-23 |
|
TVA Medical (Austin, TX) a development-stage medical device company focused on a minimally invasive approach for the treatment of end-stage renal disease, closed a $2.6M Series A financing. Partici...
|
|
|
|
